The global hydrocephalus shunts market reached a value of US$ 412.6 Million in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 540.4 Million by 2027 exhibiting a CAGR of 4.20% during 2022-2027.
Hydrocephalus shunts are medical devices used to treat a condition that develops when fluid accumulates in the brain and causes increased intracranial pressure in the skull. They are flexible tubes placed in the area of the brain where cerebrospinal fluid (CSF) is produced. Some commonly available variants include valves, catheters, fixed pressure valves, and adjustable pressure valves. They consist of a valve mechanism that regulates intracranial pressure by controlling fluid flow, an inflow or proximal catheter that drains CSF from the lateral ventricles, and an outflow or distal catheter that runs under the skin and directs CSF. Since they assist in returning the enlarged ventricles of the brain to their actual size and soothe the tension on the cerebrum, hydrocephalus shunts find extensive applications in the healthcare industry.
Ask Analyst for customized Report with TOC & List of Figure: https://www.imarcgroup.com/hydrocephalus-shunts-market/requestsample
Important Attribute and highlights of the Report:
- Detailed analysis of the global market share
- Market Segmentation by type, product type, age group, end user and region.
- Historical, current, and projected size of the market in terms of volume and value
- Latest industry trends and developments
- Competitive Landscape for Hydrocephalus Shunts Market
- Strategies of major players and product offerings
The global hydrocephalus shunts market is primarily driven by the increasing neurological and brain disorders among individuals. Moreover, the rising usage of hydrocephalus shunts due to the growing incidences of congenital abnormalities, brain and nerve injury, accidents resulting in central nervous system (CNS) disorders, and lifestyle diseases has accelerated the product adoption rate.
Additionally, the surging product demand to treat hydrocephalus among infants, which can damage the brain and lead to head enlargement, has catalyzed market growth. Furthermore, recent technological advancements, such as the development of anti-siphon devices to help prevent siphon effects over cerebrospinal fluid and programmable valves to regulate and stop cerebrospinal fluid from flowing in the wrong direction, are other major growth-inducing factors. Other factors, including supportive government policies, rapid growth in the healthcare industry, and product innovations, are also anticipated to propel the market growth.
Key Players Included in Global Research Report:
- Argi Group
- B. Braun Melsungen AG
- Christoph Miethke GmbH & Co. KG
- G. Surgiwear Ltd.
- HLL Lifecare Limited
- Integra LifeSciences
- Kaneka Medix Corporation (Kaneka Corporation)
- Medtronic Plc
- Natus Medical Incorporated
- Spiegelberg GmbH & Co. KG (SHS Medizintechnik Holding GmbH)
- TKB Corporation.
Do you know more information, Contact to our analyst at– https://www.imarcgroup.com/hydrocephalus-shunts-market
Note: As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Breakup by Type:
Breakup by Product Type:
Breakup by Age Group:
Breakup by End User:
- Ambulatory Surgical Centers
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
TOC for the Hydrocephalus Shunts Market Research Report:
- Scope and Methodology
- Executive Summary
- Global Hydrocephalus Shunts Market
- SWOT Analysis
- Value Chain Analysis
- Price Analysis
- Competitive Landscape
Who we are:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800